WO2023019924A1 - Use of caffeol or derivative thereof in preparation of anti-candida-albicans drug or anti-candida-albicans daily articles - Google Patents

Use of caffeol or derivative thereof in preparation of anti-candida-albicans drug or anti-candida-albicans daily articles Download PDF

Info

Publication number
WO2023019924A1
WO2023019924A1 PCT/CN2022/080168 CN2022080168W WO2023019924A1 WO 2023019924 A1 WO2023019924 A1 WO 2023019924A1 CN 2022080168 W CN2022080168 W CN 2022080168W WO 2023019924 A1 WO2023019924 A1 WO 2023019924A1
Authority
WO
WIPO (PCT)
Prior art keywords
candida albicans
candida
albicans
kahweol
cafestol
Prior art date
Application number
PCT/CN2022/080168
Other languages
French (fr)
Chinese (zh)
Inventor
邓音乐
宋施豪
王歌润
谭慧慧
Original Assignee
中山大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中山大学 filed Critical 中山大学
Publication of WO2023019924A1 publication Critical patent/WO2023019924A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the invention belongs to the technical field of biomedicine, and particularly relates to the application of cafestol or derivatives thereof in preparing anti-candida medicaments or anti-candida daily necessities.
  • Candida albicans (Candida albicans) is a fungal disease widely spread in humans. It is an important opportunistic pathogenic fungus, usually causing acute, subacute or chronic infections, and it is also one of the most important pathogens of hospital-acquired infections. . On healthy human mucosal surfaces, such as the oral cavity and intestinal tract, Candida albicans usually does not cause disease, but in patients with compromised or suppressed immune systems, such as chemotherapy patients, organ transplant patients or AIDS patients, it can cause serious systemic damage. Sexual infection, the fatality rate is as high as 40%.
  • fluconazole drugs that play a bacteriostatic effect by inhibiting fungal replication, but with the abuse of antibiotics, the phenomenon of drug resistance is becoming more and more serious. It's getting serious.
  • the purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art, and provide the application of cafestol or its derivatives in the preparation of anti-Candida albicans medicine or anti-Candida albicans daily necessities.
  • the object of the present invention is achieved through the following technical scheme: the application of cafestol or its derivatives in the preparation of anti-Candida albicans medicine or anti-Candida albicans daily necessities.
  • the derivative is preferably kahweol, the CAS number is 6894-43-5, and its structural formula is as follows:
  • Described cafestol also known as coffee oil alcohol, CAS number is 469-83-0, and its structural formula is as follows:
  • the anti-Candida albicans refers to inhibiting the adhesion, mycelia formation, biofilm formation, and pathogenicity of Candida albicans (infection and pathogenicity of Candida albicans).
  • the anti-Candida medicaments include medicaments for preventing and/or treating Candida albicans infection, and medicaments for preventing and/or treating infectious diseases caused by Candida albicans.
  • the daily necessities are preferably mouthwash or vaginal lotion.
  • Yeast-mycelium diphasia is a unique characteristic of Candida albicans.
  • the free yeast state is not pathogenic to the host during infection, and it mainly performs the role of adhering to the recipient tissue, and then undergoes a transformation from yeast state to mycelial state to promote invasion, and then invades in the form of mycelium Infect the host tissue and further play the role of virulence.
  • Yeast-hyphae morphological transformation is an important process for Candida albicans to exert virulence. Therefore, in the previous research work of the present invention, starting from the unique yeast-hyphae duality of Candida albicans, targeted screening of compounds with high efficiency, low toxicity, and less resistance to drugs.
  • Candida albicans Candida albicans
  • Candida albicans Candida albicans
  • the purpose is to further affect the infection of Candida albicans by detecting the interference of cafestol and cafestyl alcohol on the virulence factors of Candida albicans.
  • cafestol and cafestyl alcohol do not affect human cells and are non-toxic to human cells. Therefore, kahweol and cafestyl alcohol have good application prospects in the development of new antifungal drugs, especially the development of anti-Candida albicans infection drugs
  • Figure 1 is a photomicrograph showing that kahweol and kahweol at a final concentration of 30 ⁇ g/mL respectively inhibit the formation of Candida albicans hyphae; wherein, a DMSO control group was set.
  • Figure 2 is a graph showing the measurement results of cafestol and cafestyl alcohol respectively inhibiting the hyphae formation rate of Candida albicans; this data shows the average results of three biological experiments, and the error bars reflect the standard deviation.
  • Figure 3 is a graph showing the results of cafestol and cafestyl alcohol respectively inhibiting the adhesion of Candida albicans; wherein, DMSO was used as a control group; the data shows the average results of 4 biological repetitions, and the error bars reflect the standard deviation.
  • Figure 4 is a graph showing the results of cafestol and cafestyl alcohol respectively inhibiting the formation of Candida albicans biofilm; wherein, DMSO was used as a control group; the data shows the average results of 4 biological repetitions, and the error bars reflect the standard deviation.
  • Figure 5 is a graph showing the effects of cafestol and cafestyl alcohol on the growth rate of Candida albicans respectively; wherein, DMSO is used as a control; the data shows the average results of 3 biological repetitions, and the error bars reflect the standard deviation.
  • Figure 6 is a graph showing the effects of kahweol and kahweol on the toxicity of Candida albicans on A549 cells; among them, Figure A is the cytotoxicity detection of kahweol and kahweol at a final concentration of 30 ⁇ g/mL on A549 cells Result chart; Figure B is the detection result chart after different concentrations of kahweol and kahweol inhibit Candida albicans from infecting cells.
  • Fig. 7 is a graph showing the results of detection of cafestol on oral cavity infection of Candida albicans strain SC5314 in mice.
  • the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field.
  • Candida albicans standard strain SC5314 (named also ATCC MYA-2876) was activated in LB solid medium (tryptone 10g/L, yeast extract 5g/L, NaCl 10g/L, agar 15g/L), placed in 30 Cultivate overnight in an incubator.
  • A549 cell preparation A549 cells were cultured overnight in a 96-well plate at a cell concentration of 0.5 ⁇ 10 3 cells/well in high-glucose medium DMEM containing 10% fetal bovine serum. When the cells covered 80% of the bottom of the 96-well plate, the culture medium was discarded, and the cells were washed 3 times with 1 ⁇ PBS.
  • the mother liquor Dilute the cafestyl alcohol mother liquor and the cafestyl alcohol mother liquor (the mother liquor is prepared with DMSO) with DMSO to dilute the concentration of 6mg/mL, 3mg/mL, 1.5mg/mL, 0.75mg/mL respectively, and then the cafestol alcohol
  • the diluent and the diluent of cafestyl alcohol were respectively mixed with the cell maintenance solution containing bacteria at a volume ratio of 1:199, oscillated and mixed to obtain the test solution A, and the final concentrations of cafestyl alcohol and cafestyl alcohol in the test solution A were respectively 30 ⁇ g/mL, 15 ⁇ g/mL, 7.5 ⁇ g/mL, 3.75 ⁇ g/mL.
  • step (b) Add 100 ⁇ L/well to the 96-well plate of the cultured cells in step (b), and set 4 repetitions for each treatment; set up the treatment of adding only DMSO at the same time, wherein, the volume ratio of DMSO and bacteria-containing cell maintenance solution is 1: 199 ratio mixed to obtain the test solution B.
  • the 96-well plate was incubated at 37° C., and the culture medium was discarded after 1.5 h, and 100 ⁇ L of crystal violet solution with a concentration of 0.5% (w/v) was added to each well for 45 min at room temperature. Discard the crystal violet, wash with ice ddH 2 O 10 times, add 100 ⁇ L of 75% by volume ethanol solution, leave at room temperature for 30 min, measure OD 570 , and process data with GraphPad Prism 6 software.
  • GMM culture solution 6.g/L YNB, 0.2% glucose
  • A549 cell preparation A549 cells were cultured overnight in a 96-well plate at a cell concentration of 1.5 ⁇ 10 4 cells/well in high-glucose medium DMEM containing 10% fetal bovine serum. When the cells covered 80% of the bottom of the 96-well plate, the culture medium was discarded, and the cells were washed 3 times with 1 ⁇ PBS.
  • a) Determination of the cytotoxic effect of kahweol and kahweol itself on cells Dilute kahweol and kahweol to 6 mg/mL with DMSO, respectively, and add them to the cell maintenance solution. The final concentrations of kahweol and kahweol are 30 ⁇ g, respectively. /mL to obtain test solution E; at the same time, set up a control group and take the same volume of DMSO to obtain test solution F. Add test solution E and test solution F to the prepared A549 cells at 100 ⁇ L/well, place them in a 37°C, 5% CO 2 cell incubator and incubate them for 8 hours, with 4 replicates per treatment.
  • b) Determination of the cytotoxicity of kahweol and kahweol to Candida albicans Dilute kahweol and kahweol with DMSO to concentrations of 6 mg/mL, 3 mg/mL, 1.5 mg/mL, and 0.75 mg/mL, respectively. mL of the diluted drug solution, and then the cafestyl alcohol dilution and the cafestyl alcohol dilution were mixed with the cell maintenance solution containing bacteria at a volume ratio of 1:199 to obtain the test solution G. The final concentrations in solution G were 30 ⁇ g/mL, 15 ⁇ g/mL, 7.5 ⁇ g/mL, and 3.75 ⁇ g/mL respectively.
  • test solution G the volume content of DMSO was basically the same; sulfone) as a control, wherein DMSO and bacteria-containing cell maintenance solution were mixed in a volume ratio of 1:199 to obtain test solution H.
  • mice 6-8 week-old male BALB/c mice purchased from Guangdong Experimental Animal Center were bred in the Experimental Animal Center of South China Agricultural University. Randomly assign 8 mice/group, weigh and record and mark each mouse.
  • Candida albicans suspension activate Candida albicans standard strain SC5314 in LB solid medium (tryptone 10g/L, yeast extract 5g/L, NaCl 10g/L, agar 15g/L), namely Place in a 30°C incubator overnight. Take a single colony and inoculate it in GMM culture medium (6.7g/L YNB, 0.2% glucose), and cultivate overnight at 30°C on a shaker at 200rpm. Centrifuge at 4°C and 3000rpm for 5min, wash twice with pre-cooled sterile PBS, count by blood cell counting method, and prepare a bacterial suspension with a concentration of 3 ⁇ 10 6 CFU/mL. Take 5mL of bacterial suspension for later use.
  • GMM culture medium 6.g/L YNB, 0.2% glucose
  • Preparation Take 5 mL of PBS and add 25 ⁇ L of kahweol diluent (concentration: 6 mg/mL, solute is DMSO) to the final concentration of kahweol to 30 ⁇ g/mL, take 5 mL of PBS, add 25 ⁇ L of DMSO to it.
  • kahweol diluent concentration: 6 mg/mL, solute is DMSO
  • mice oral infection experiment the mice were weighed one day before infection and each injected with 0.1mL/10g of hydrocortisone (22.5mg/mL, before inoculation, the mice were anesthetized with 10% chloral hydrate , the anesthetized mice were placed flat in a constant temperature environment of 37°C, soaked in the bacterial suspension with sterile cotton balls for 3 minutes and then placed under the tongues of the mice for 90 minutes; at the same time, a blank control group was set up, and the blank control group soaked the sterile balls with PBS solution Put it under the tongue of the mouse for 90 minutes after cotton.
  • each mouse was fed with 100 ⁇ L/10 g of cafeteria alcohol dilution (the concentration was 30 ⁇ g/mL, and the solute was DMSO); at the same time, a positive control group was set , the positive control group was gavaged with PBS containing DMSO.
  • the mice were sacrificed, and the tongues of the mice were dissected and further observed in pathological sections.
  • Figure 1 is a photograph of the mycelium formation of Candida albicans observed under a microscope, in which the same volume of DMSO was added to the bacterial solution according to the kahwegol and kahweol treatment groups, and cultured at 37°C as a control group to exclude the effect of DMSO on white Effects on Candida hyphae formation. Calculate the inhibition rate of mycelium formation by photos: take 3 photos (3 photos with 3 repeated values) for one sample, count the mycelia on the photos, and the mycelium formed with DMSO is 100%.
  • the results of the cytotoxicity experiment showed that, using DMSO as a control, kahwegol or cafestyl alcohol had no toxicity to cells at a concentration of 30 ⁇ g/mL in the absence of Candida albicans, as shown in FIG. 6A .
  • Figure 6B shows that cafestol or cafestyl alcohol has a good protective effect on inhibiting the invasion of cells by SC5314; /mL concentration, the virulence of Candida albicans was reduced to below 30%.
  • Caffeol has a good inhibitory effect on the oral infection of Candida albicans strain SC5314 in mice

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided in the present invention is the use of caffeol or a derivative thereof in the preparation of an anti-Candida-albicans drug or anti-Candida-albicans daily articles. According to the present invention, a compound with high efficiency, low toxicity and not prone to developing drug resistance is selected by taking Candida albicans as a test object. It is found that caffeol or a derivative thereof has a good inhibitory effect on the adhesion, hypha formation, biofilm formation and pathogenicity of Candida albicans. Moreover, kahweol has a good inhibitory effect on the infection of a Candida albicans strain SC5314 on a mouse oral cavity, and the compound itself is not toxic to human cells. Low-concentration kahweol and cafestol have no inhibitory effect on the cell growth of Candida albicans, this indicates that the effect of caffeol or the derivative thereof involves inhibiting the expression of pathogenic factors of Candida albicans instead of relying on killing Candida albicans cells, and thus, drug resistance does not tend to develop.

Description

咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用Application of cafestol or its derivatives in the preparation of anti-candida albicans medicine or anti-candida albicans daily necessities 技术领域technical field
本发明属于生物医药技术领域,特别涉及咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用。The invention belongs to the technical field of biomedicine, and particularly relates to the application of cafestol or derivatives thereof in preparing anti-candida medicaments or anti-candida daily necessities.
背景技术Background technique
白色念珠菌(Candida albicans)是在人类中广泛传播的真菌疾病,是一种重要的条件致病真菌,通常会引起急性、亚急性或慢性感染,也是现在医院获得性感染最重要的病原之一。在健康人体黏膜表面,如口腔、肠道,白色念珠菌通常不会引起病害,但在免疫系统受到损害或抑制的病人体内,如化疗病人、器官移植病人或艾滋病人中,会引起严重的系统性感染,其致死率高达40%。Candida albicans (Candida albicans) is a fungal disease widely spread in humans. It is an important opportunistic pathogenic fungus, usually causing acute, subacute or chronic infections, and it is also one of the most important pathogens of hospital-acquired infections. . On healthy human mucosal surfaces, such as the oral cavity and intestinal tract, Candida albicans usually does not cause disease, but in patients with compromised or suppressed immune systems, such as chemotherapy patients, organ transplant patients or AIDS patients, it can cause serious systemic damage. Sexual infection, the fatality rate is as high as 40%.
目前在临床上抗真菌药物种类有限,其中唑类药物(氟康唑)应用广泛,氟康唑是通过抑制真菌复制起到抑菌的作用,但是随着抗生素的滥用,耐药性的现象越来越严重。At present, there are limited types of antifungal drugs clinically, among which azole drugs (fluconazole) are widely used, and fluconazole plays a bacteriostatic effect by inhibiting fungal replication, but with the abuse of antibiotics, the phenomenon of drug resistance is becoming more and more serious. It's getting serious.
发明内容Contents of the invention
本发明的目的在于克服现有技术的缺点与不足,提供咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用。The purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art, and provide the application of cafestol or its derivatives in the preparation of anti-Candida albicans medicine or anti-Candida albicans daily necessities.
本发明的目的通过下述技术方案实现:咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用。The object of the present invention is achieved through the following technical scheme: the application of cafestol or its derivatives in the preparation of anti-Candida albicans medicine or anti-Candida albicans daily necessities.
所述的衍生物优选为咖啡豆醇,CAS号为6894-43-5,其结构式如下所示:The derivative is preferably kahweol, the CAS number is 6894-43-5, and its structural formula is as follows:
Figure PCTCN2022080168-appb-000001
Figure PCTCN2022080168-appb-000001
所述的咖啡醇,亦称为咖啡油醇,CAS号为469-83-0,其结构式如下所示:Described cafestol, also known as coffee oil alcohol, CAS number is 469-83-0, and its structural formula is as follows:
Figure PCTCN2022080168-appb-000002
Figure PCTCN2022080168-appb-000002
具体地,所述的抗白色念珠菌是指抑制白色念珠菌的粘附性、菌丝形成、生物膜形成、致病性(白色念珠菌的侵染致病能力)。Specifically, the anti-Candida albicans refers to inhibiting the adhesion, mycelia formation, biofilm formation, and pathogenicity of Candida albicans (infection and pathogenicity of Candida albicans).
所述的抗白色念珠菌药物包括用于预防和/或治疗白色念珠菌感染的药物,以及用于预防和/或治疗白色念珠菌引起的感染性疾病药物。The anti-Candida medicaments include medicaments for preventing and/or treating Candida albicans infection, and medicaments for preventing and/or treating infectious diseases caused by Candida albicans.
所述的日用品优选为漱口水或阴道洗液。The daily necessities are preferably mouthwash or vaginal lotion.
本发明具有以下有益效果:The present invention has the following beneficial effects:
酵母-菌丝二相性是白色念珠菌特有的特性。游离的酵母态在感染期间对于宿主是没有致病性的,主要行使粘附于受体组织的作用,随后进行由酵母态向菌丝态的转变以促进入侵,之后以菌丝态的形式侵染寄主组织,进一步发挥致病毒力作用。酵母-菌丝的形态转变是白色念珠菌发挥毒力的重要过程。因此,本发明在前期的研究工作中,从白色念珠菌特有的酵母-菌丝二相性入手,针对性地筛选高效、低毒、不易产生耐药性的化合物。然后以白色念珠菌(Candida albicans)为供试对象,分别考察了本发明筛选的咖啡豆醇和咖啡油醇对白色念珠菌的粘附性、菌丝形成率、生物膜形成以及细胞毒力的影响作用,目的是通过检测咖啡豆醇和咖啡油醇对白色念珠菌毒力因子的干扰,进一步影响白色念珠菌的侵染作用。结果显示,高浓度的咖啡豆醇对白色念珠菌的生长具有轻微的抑制作用,低浓度的咖啡豆醇和咖啡油醇对白色念珠菌的生长没有抑制作用且它们都对白色念珠菌的粘附性、菌丝形成、生物膜形成和致病性具有很好的抑制作用,表明咖啡豆醇和咖啡油醇对白色念珠菌的毒力抑制作用并不主要是依靠杀死白色念珠菌细胞,而是通过抑制白色念珠菌的粘附性、菌丝形成、生物膜形成和致病性达到的,因此不易产生耐药性。而且,咖啡豆醇和咖啡油醇不影响人体细胞,对人体细胞无毒。因此,咖啡豆醇和咖啡油醇在新型抗真菌药物的开发,尤其是抗白色念珠菌感染药物的开发方面具有很好的应用前景Yeast-mycelium diphasia is a unique characteristic of Candida albicans. The free yeast state is not pathogenic to the host during infection, and it mainly performs the role of adhering to the recipient tissue, and then undergoes a transformation from yeast state to mycelial state to promote invasion, and then invades in the form of mycelium Infect the host tissue and further play the role of virulence. Yeast-hyphae morphological transformation is an important process for Candida albicans to exert virulence. Therefore, in the previous research work of the present invention, starting from the unique yeast-hyphae duality of Candida albicans, targeted screening of compounds with high efficiency, low toxicity, and less resistance to drugs. Then with Candida albicans (Candida albicans) as test object, investigated respectively the influence of kahwegol and cafeteria alcohol screened by the present invention on the adhesion, hyphal formation rate, biofilm formation and cytotoxicity of Candida albicans The purpose is to further affect the infection of Candida albicans by detecting the interference of cafestol and cafestyl alcohol on the virulence factors of Candida albicans. The results showed that high concentrations of kahweol had a slight inhibitory effect on the growth of Candida albicans, low concentrations of kahweol and cafestyl alcohol had no inhibitory effect on the growth of Candida albicans, and they all had the ability to adhere to Candida albicans , mycelia formation, biofilm formation and pathogenicity have very good inhibitory effects, indicating that the inhibitory effect of cafestol and cafestyl alcohol on the virulence of Candida albicans is not mainly by killing Candida albicans cells, but by Inhibit the adhesion, mycelia formation, biofilm formation and pathogenicity of Candida albicans, so it is not easy to produce drug resistance. Moreover, cafestol and cafestyl alcohol do not affect human cells and are non-toxic to human cells. Therefore, kahweol and cafestyl alcohol have good application prospects in the development of new antifungal drugs, especially the development of anti-Candida albicans infection drugs
因此,咖啡豆醇和咖啡油醇在制备抗白色念珠菌感染的药物中的应用,以及在制备预防和/或治疗白色念珠菌引起的感染性疾病的药物中的应用,均应在本发明的保护范围之内。Therefore, the application of cafestyl alcohol and cafestyl alcohol in the preparation of medicines against Candida albicans infection, and the application of medicines in the preparation of prevention and/or treatment of infectious diseases caused by Candida albicans should be protected under the protection of the present invention. within range.
附图说明Description of drawings
图1是终浓度为30μg/mL的咖啡豆醇和咖啡油醇分别抑制白色念珠菌菌丝生成的显微镜照片图;其中,设置了DMSO对照组。Figure 1 is a photomicrograph showing that kahweol and kahweol at a final concentration of 30 μg/mL respectively inhibit the formation of Candida albicans hyphae; wherein, a DMSO control group was set.
图2是咖啡豆醇和咖啡油醇分别抑制白色念珠菌菌丝形成率的测定结果图;此数据显示的是3次生物学实验的平均结果,误差棒反映了标准差。Figure 2 is a graph showing the measurement results of cafestol and cafestyl alcohol respectively inhibiting the hyphae formation rate of Candida albicans; this data shows the average results of three biological experiments, and the error bars reflect the standard deviation.
图3是咖啡豆醇和咖啡油醇分别抑制白色念珠菌粘附性的结果图;其中,DMSO作为对照组;数据显示的是4个生物学重复的平均结果,误差棒反映了标准差。Figure 3 is a graph showing the results of cafestol and cafestyl alcohol respectively inhibiting the adhesion of Candida albicans; wherein, DMSO was used as a control group; the data shows the average results of 4 biological repetitions, and the error bars reflect the standard deviation.
图4是咖啡豆醇和咖啡油醇分别抑制白色念珠菌生物膜形成的结果图;其中,DMSO作为对照组;数据显示的是4个生物学重复的平均结果,误差棒反映了标准差。Figure 4 is a graph showing the results of cafestol and cafestyl alcohol respectively inhibiting the formation of Candida albicans biofilm; wherein, DMSO was used as a control group; the data shows the average results of 4 biological repetitions, and the error bars reflect the standard deviation.
图5是咖啡豆醇和咖啡油醇分别对白色念珠菌生长速率的影响结果图;其中,DMSO作为对照;数据显示的是3个生物学重复的平均结果,误差棒反映了标准差。Figure 5 is a graph showing the effects of cafestol and cafestyl alcohol on the growth rate of Candida albicans respectively; wherein, DMSO is used as a control; the data shows the average results of 3 biological repetitions, and the error bars reflect the standard deviation.
图6是咖啡豆醇和咖啡油醇对白色念珠菌分别在A549细胞毒力方面的影响结果图;其中,图A是终浓度为30μg/mL的咖啡豆醇和咖啡油醇对A549细胞的细胞毒性检测结果图;图B是不同浓度的咖啡豆醇和咖啡油醇抑制白色念珠菌侵染细胞后的检测结果图。Figure 6 is a graph showing the effects of kahweol and kahweol on the toxicity of Candida albicans on A549 cells; among them, Figure A is the cytotoxicity detection of kahweol and kahweol at a final concentration of 30 μg/mL on A549 cells Result chart; Figure B is the detection result chart after different concentrations of kahweol and kahweol inhibit Candida albicans from infecting cells.
图7是咖啡豆醇对白色念珠菌菌株SC5314的小鼠口腔侵染检测结果图。Fig. 7 is a graph showing the results of detection of cafestol on oral cavity infection of Candida albicans strain SC5314 in mice.
具体实施方式Detailed ways
下面结合实施例及附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。The present invention will be further described in detail below in conjunction with the embodiments and the accompanying drawings, but the embodiments of the present invention are not limited thereto.
除非特别说明,本发明采用的试剂、方法和设备为本技术领域常规试剂、方法和设备。Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field.
除非特别说明,以下实施例所用试剂和材料均为市购。Unless otherwise specified, the reagents and materials used in the following examples are commercially available.
实施例1 咖啡豆醇和咖啡油醇抗菌活性检测Example 1 Detection of kahweol and kahweol antibacterial activity
1、试验方法:1. Test method:
(1)白色念珠菌菌株的活化:(1) Activation of Candida albicans strains:
将白色念珠菌标准菌株SC5314(名称亦为ATCC MYA-2876)于LB固体培养基活化(胰蛋白胨10g/L、酵母提取物5g/L、NaCl 10g/L、琼脂15g/L),置于30℃培养箱培养过夜。Candida albicans standard strain SC5314 (named also ATCC MYA-2876) was activated in LB solid medium (tryptone 10g/L, yeast extract 5g/L, NaCl 10g/L, agar 15g/L), placed in 30 Cultivate overnight in an incubator.
(2)咖啡豆醇和咖啡油醇对白色念珠菌菌株SC5314菌丝的影响:(2) Effects of cafestol and cafestol on mycelia of Candida albicans strain SC5314:
挑取LB固体平板上(胰蛋白胨10g/L、酵母提取物5g/L、NaCl 10g/L、琼脂15g/L)的SC5314菌株,接种于GMM培养液(6.7g/L YNB、0.2%葡萄糖)中,30℃、200rpm振荡培养过夜,测定菌液OD 600,用GMM将菌液稀释至OD 600=0.1。取500μL菌液于1.5mL EP管中,加入咖啡豆醇和咖啡油醇,终浓度为30μg/mL;同时设置DMSO对照;DMSO对照组中DMSO按咖啡豆醇和咖啡油醇处理组的相同体积加入到菌液中得到。震荡混匀,置于37℃水浴锅中孵育,6h后,离心5000rpm,10min,弃上清,加入40μL GMM培养液重悬菌体,于Zeiss Axioplan 2显微镜下观察菌丝的形成,取不同视野拍摄照片,并计算菌丝形成率。 Pick the SC5314 strain on the LB solid plate (tryptone 10g/L, yeast extract 5g/L, NaCl 10g/L, agar 15g/L) and inoculate it in GMM culture medium (6.7g/L YNB, 0.2% glucose) medium, 30°C, 200rpm shaking culture overnight, measure the OD 600 of the bacterial solution, and dilute the bacterial solution to OD 600 =0.1 with GMM. Take 500 μL of bacterial liquid in a 1.5mL EP tube, add kahweol and kahweol, the final concentration is 30 μg/mL; set DMSO control at the same time; in the DMSO control group, DMSO is added to the obtained from bacterial fluid. Shake and mix well, and incubate in a water bath at 37°C. After 6 hours, centrifuge at 5,000 rpm for 10 minutes, discard the supernatant, add 40 μL of GMM culture medium to resuspend the bacteria, and observe the formation of hyphae under a Zeiss Axioplan 2 microscope, taking different fields of view Photographs were taken, and the mycelium formation rate was calculated.
(3)咖啡豆醇和咖啡油醇对白色念珠菌菌株SC5314粘附性的影响:(3) Effects of cafestol and cafestyl alcohol on the adhesion of Candida albicans strain SC5314:
(a)人非小细胞肺癌细胞系A549细胞的复苏及培养:将冻融的A549细胞转移至含10%(v/v)FBS的DMEM培养基(Gibco公司)中,37℃、5%CO 2条件下过夜培养。 (a) Recovery and cultivation of human non-small cell lung cancer cell line A549 cells: transfer the frozen-thawed A549 cells to DMEM medium (Gibco Company) containing 10% (v/v) FBS, 37 ° C, 5% CO 2 conditions overnight.
(b)A549细胞准备:A549细胞在含10%胎牛血清的高糖培养基DMEM中,以0.5×10 3个/孔的细胞浓度于96孔板中培养过夜。待细胞布满96孔板底部80%的时候,弃去培养液,用1×PBS清洗细胞3次。 (b) A549 cell preparation: A549 cells were cultured overnight in a 96-well plate at a cell concentration of 0.5×10 3 cells/well in high-glucose medium DMEM containing 10% fetal bovine serum. When the cells covered 80% of the bottom of the 96-well plate, the culture medium was discarded, and the cells were washed 3 times with 1×PBS.
(c)挑取LB固体平板上的SC5314菌株,接种于GMM培养液(6.7g/L YNB、0.2%葡萄糖)中,30℃,200rpm振荡培养过夜,测定菌液OD 600。随后用细胞维持液(含1%v/v FBS的DMEM)调节将菌液稀释至OD 600=0.5。将咖啡豆醇母液和咖啡油醇母液(母液用DMSO配制)分别用DMSO稀释成浓度为6mg/mL、3mg/mL、1.5mg/mL、0.75mg/mL的稀释药液,然后将咖啡豆醇稀释液、咖啡油醇稀释液分别与含菌的细胞维持液按体积比1:199配比混合,震荡混匀,得到测试液A,咖啡豆醇和咖啡油醇在测试液A中的终浓度分别为30μg/mL、15μg/mL、7.5μg/mL、3.75μg/mL。按100μL/孔加入步骤(b)已培养细胞的96孔板中,每个处理设置4个重复;同时设置只加DMSO的处理,其中,以DMSO和含菌的细胞维持液按体积比1:199配比混合,得到测试液B。将96孔板静置于37℃中孵育,1.5h后弃掉培养液,每孔加入100μL浓度为0.5%(w/v)的结晶紫溶液,室温作用45min。将结晶紫弃掉,并用冰ddH 2O洗10次,加入100μL浓度为体积百分比75%的乙醇溶液,室温放置30min,测定OD 570,用GraphPad Prism 6软件处理数据。 (c) Pick the SC5314 strain on the LB solid plate, inoculate it in GMM culture solution (6.7g/L YNB, 0.2% glucose), culture it overnight at 30°C with shaking at 200rpm, and measure the OD 600 of the bacterial solution. Then adjust and dilute the bacterial solution to OD 600 =0.5 with cell maintenance solution (DMEM containing 1% v/v FBS). Dilute the cafestyl alcohol mother liquor and the cafestyl alcohol mother liquor (the mother liquor is prepared with DMSO) with DMSO to dilute the concentration of 6mg/mL, 3mg/mL, 1.5mg/mL, 0.75mg/mL respectively, and then the cafestol alcohol The diluent and the diluent of cafestyl alcohol were respectively mixed with the cell maintenance solution containing bacteria at a volume ratio of 1:199, oscillated and mixed to obtain the test solution A, and the final concentrations of cafestyl alcohol and cafestyl alcohol in the test solution A were respectively 30μg/mL, 15μg/mL, 7.5μg/mL, 3.75μg/mL. Add 100 μL/well to the 96-well plate of the cultured cells in step (b), and set 4 repetitions for each treatment; set up the treatment of adding only DMSO at the same time, wherein, the volume ratio of DMSO and bacteria-containing cell maintenance solution is 1: 199 ratio mixed to obtain the test solution B. The 96-well plate was incubated at 37° C., and the culture medium was discarded after 1.5 h, and 100 μL of crystal violet solution with a concentration of 0.5% (w/v) was added to each well for 45 min at room temperature. Discard the crystal violet, wash with ice ddH 2 O 10 times, add 100 μL of 75% by volume ethanol solution, leave at room temperature for 30 min, measure OD 570 , and process data with GraphPad Prism 6 software.
(4)咖啡豆醇和咖啡油醇对白色念珠菌菌株SC5314生物膜形成的影响:(4) Effects of cafestol and cafestyl alcohol on biofilm formation of Candida albicans strain SC5314:
挑取LB固体平板上的SC5314菌株,接种于GMM培养液(6.7g/L YNB,0.2%葡萄糖),30℃、200rpm振荡培养过夜,测定菌液OD 600。随后用GMM培养液将菌液稀释至OD 600=0.1,得到含菌的GMM培养液。将咖啡豆醇母液和咖啡油醇母液用DMSO稀释成浓度为6mg/mL、3mg/mL、1.5mg/mL、0.75mg/mL的稀释药液,然后将咖啡豆醇稀释液、咖啡油醇稀释液分别与含菌的GMM培养液按体积比1:199配比混合,震荡混匀,得到测试液D,咖啡豆醇和咖啡油醇在测试液D中的终浓度分别为30μg/mL、15μg/mL、7.5μg/mL、3.75μg/mL。按100μL/孔加入96孔板中,每个处理设置4个重复,同时设置只加DMSO的对照组。将96孔板静置于37℃中孵育,8h后弃掉培养液,加入100μL浓度为0.5%w/v的结晶紫,室温作用45min。将结晶紫弃掉,并用冰ddH 2O洗10次,加入100μL 75%乙醇,室温放置30min,测定OD 570,用GraphPad Prism 6软件处理数据。 The SC5314 strain on the LB solid plate was picked, inoculated in GMM culture solution (6.7g/L YNB, 0.2% glucose), cultured overnight at 30°C with shaking at 200rpm, and the OD 600 of the bacterial solution was measured. Then the bacterial solution was diluted to OD 600 =0.1 with GMM culture solution to obtain the GMM culture solution containing bacteria. Dilute the cafestyl alcohol mother liquor and the cafestyl alcohol mother liquor with DMSO to dilute the concentration of 6mg/mL, 3mg/mL, 1.5mg/mL, 0.75mg/mL, and then dilute the cafestyl alcohol dilution and cafeteria alcohol solution was mixed with the GMM culture solution containing bacteria at a volume ratio of 1:199, oscillated and mixed to obtain test solution D, and the final concentrations of cafestol and cafestyl alcohol in test solution D were 30 μg/mL and 15 μg/mL, respectively. mL, 7.5 μg/mL, 3.75 μg/mL. 100 μL/well was added to a 96-well plate, and 4 replicates were set for each treatment, and a control group with only DMSO was set at the same time. The 96-well plate was incubated at 37° C., and the culture medium was discarded after 8 hours, and 100 μL of crystal violet with a concentration of 0.5% w/v was added for 45 minutes at room temperature. Discard the crystal violet, wash with ice ddH 2 O 10 times, add 100 μL of 75% ethanol, let stand at room temperature for 30 min, measure OD 570 , and process data with GraphPad Prism 6 software.
(5)咖啡豆醇和咖啡油醇对白色念珠菌菌株SC5314生长影响测定:(5) Determination of the influence of cafestol and cafestyl alcohol on the growth of Candida albicans strain SC5314:
挑取菌株SC5314单菌落接种于GMM培养液(6.7g/L YNB、0.2%葡萄糖),30℃、200rpm振荡培养过夜,测定菌液OD 600,用GMM将菌液稀释至OD 600=0.05。将咖啡豆醇母液和咖啡油醇母液用DMSO稀释成浓度为6mg/mL、3mg/mL、1.5mg/mL、0.75mg/mL的稀释药液,然后将咖啡豆醇稀释液、咖啡油醇稀释液分别与含菌的GMM培养液按体积比1:199配比混合,按300μL/孔的量加入到100孔板中,每个处理设置3个重复,同时设置只加DMSO的处理。置于生长曲线测定仪中,30℃、200rpm,每2h测定一次OD 600值,20h后观察实验结果,GraphPad Prism 6处理数据。 Pick a single colony of strain SC5314 and inoculate it in GMM medium (6.7g/L YNB, 0.2% glucose), culture overnight at 30°C with shaking at 200rpm, measure the OD 600 of the bacterial solution, and dilute the bacterial solution to OD 600 =0.05 with GMM. Dilute the cafestyl alcohol mother liquor and the cafestyl alcohol mother liquor with DMSO to dilute the concentration of 6mg/mL, 3mg/mL, 1.5mg/mL, 0.75mg/mL, and then dilute the cafestyl alcohol dilution and cafeteria alcohol solution was mixed with the GMM culture medium containing bacteria at a volume ratio of 1:199, and added to a 100-well plate at an amount of 300 μL/well. Each treatment was set up with 3 replicates, and at the same time, only DMSO was added to the treatment. Place in a growth curve analyzer at 30°C and 200 rpm, measure the OD 600 value every 2 hours, observe the experimental results after 20 hours, and process the data with GraphPad Prism 6.
(6)咖啡豆醇和咖啡油醇对白色念珠菌菌株SC5314细胞毒力的影响:(6) Effects of cafestol and cafestol on the cytotoxicity of Candida albicans strain SC5314:
(a)人非小细胞肺癌细胞系A549细胞的复苏及培养:将冻融的A549细胞转移至含10%(v/v)FBS的DMEM培养基(Gibco公司)中,37℃、5%CO 2条件下过夜培养。 (a) Recovery and cultivation of human non-small cell lung cancer cell line A549 cells: transfer the frozen-thawed A549 cells to DMEM medium (Gibco Company) containing 10% (v/v) FBS, 37 ° C, 5% CO 2 conditions overnight.
(b)A549细胞准备:A549细胞在含10%胎牛血清的高糖培养基DMEM中,以1.5×10 4个/孔的细胞浓度于96孔板中培养过夜。待细胞布满96孔板底部80%的时候,弃去培养液,用1×PBS清洗细胞3次。 (b) A549 cell preparation: A549 cells were cultured overnight in a 96-well plate at a cell concentration of 1.5×10 4 cells/well in high-glucose medium DMEM containing 10% fetal bovine serum. When the cells covered 80% of the bottom of the 96-well plate, the culture medium was discarded, and the cells were washed 3 times with 1×PBS.
(c)白色念珠菌准备:挑取新鲜SC5314接种于GMM培养液(6.7g/L YNB,0.2%葡萄糖)中,于30℃、200rpm条件下振荡培养过夜;用细胞维持液(含1%FBS的DMEM)调节至OD 600=1.0,再用细胞维持液稀释10倍(≈10 8CFU/mL),得到含菌的细胞维持液。 (c) Preparation of Candida albicans: pick fresh SC5314 and inoculate it in GMM culture medium (6.7g/L YNB, 0.2% glucose), shake and cultivate overnight at 30°C and 200rpm; use cell maintenance medium (containing 1% FBS DMEM) adjusted to OD 600 =1.0, and then diluted 10 times with cell maintenance solution (≈10 8 CFU/mL) to obtain cell maintenance solution containing bacteria.
(d)细胞毒力测定:(d) Cytotoxicity assay:
a)测定咖啡豆醇和咖啡油醇本身对细胞的毒性作用:将咖啡豆醇和咖啡油醇分别用DMSO稀释到6mg/mL,加入细胞维持液中,咖啡豆醇和咖啡油醇的终浓度分别为30μg/mL,得到测试液E;同时,设置对照组,取相同体积的DMSO,得到测试液F。按100μL/孔,将测试液E和测试液F分别加入准备好的A549细胞中,置于37℃、5%CO 2细胞培养箱内培养8h,每处理4个重复。 a) Determination of the cytotoxic effect of kahweol and kahweol itself on cells: Dilute kahweol and kahweol to 6 mg/mL with DMSO, respectively, and add them to the cell maintenance solution. The final concentrations of kahweol and kahweol are 30 μg, respectively. /mL to obtain test solution E; at the same time, set up a control group and take the same volume of DMSO to obtain test solution F. Add test solution E and test solution F to the prepared A549 cells at 100 μL/well, place them in a 37°C, 5% CO 2 cell incubator and incubate them for 8 hours, with 4 replicates per treatment.
b)测定咖啡豆醇和咖啡油醇对白色念珠菌对细胞的毒力作用:将咖啡豆醇和咖啡油醇分别用DMSO稀释成浓度为6mg/mL、3mg/mL、1.5mg/mL、0.75mg/mL的稀释药液,然后将咖啡豆醇稀释液和咖啡油醇稀释液分别与含菌的细胞维持液按体积比1:199配比混合,得到测试液G,咖啡豆醇和咖啡油醇在测试液G中的终浓度分别为30μg/mL、15μg/mL、7.5μg/mL、3.75μg/mL,测试液G中,DMSO的体积含量基本是相同的;同时设置只加DMSO(二甲基亚砜)作为对照,其中,以DMSO和含菌的细胞维持液按体积比1:199配比混合,得到测试液H。按100μL/孔,将测试液G、H分别加入准备好的A549细胞中,置于37℃、5%CO 2细胞培养箱内培养8h,每处理4个重复。 b) Determination of the cytotoxicity of kahweol and kahweol to Candida albicans: Dilute kahweol and kahweol with DMSO to concentrations of 6 mg/mL, 3 mg/mL, 1.5 mg/mL, and 0.75 mg/mL, respectively. mL of the diluted drug solution, and then the cafestyl alcohol dilution and the cafestyl alcohol dilution were mixed with the cell maintenance solution containing bacteria at a volume ratio of 1:199 to obtain the test solution G. The final concentrations in solution G were 30 μg/mL, 15 μg/mL, 7.5 μg/mL, and 3.75 μg/mL respectively. In test solution G, the volume content of DMSO was basically the same; sulfone) as a control, wherein DMSO and bacteria-containing cell maintenance solution were mixed in a volume ratio of 1:199 to obtain test solution H. Add test solutions G and H to the prepared A549 cells at 100 μL/well, respectively, and place them in a 37°C, 5% CO 2 cell incubator for 8 hours, with 4 replicates per treatment.
c)参照Promega公司CytoTox
Figure PCTCN2022080168-appb-000003
NonRadioactive Cytotoxicity Assay操作方法测定细胞LDH活性,随后用GraphPad Prism 6处理数据。
c) Refer to Promega CytoTox
Figure PCTCN2022080168-appb-000003
The NonRadioactive Cytotoxicity Assay method was used to measure cellular LDH activity, and then the data was processed with GraphPad Prism 6.
(7)测定咖啡豆醇和咖啡油醇对白色念珠菌菌株SC5314小鼠口腔侵染的影响:(7) Determination of the influence of cafestol and cafestyl alcohol on the oral infection of Candida albicans strain SC5314 mice:
(a)小鼠饲养:购于广东省实验动物中心的6~8周龄的雄性BALB/c小鼠,于华南农业大学实验动物中心饲养。随机分配8只/组,称重记录并给每只小鼠做好标记。(a) Breeding of mice: 6-8 week-old male BALB/c mice purchased from Guangdong Experimental Animal Center were bred in the Experimental Animal Center of South China Agricultural University. Randomly assign 8 mice/group, weigh and record and mark each mouse.
(b)白色念珠菌菌悬液制备:将白色念珠菌标准菌株SC5314于LB固体培养基活化(胰蛋白胨10g/L、酵母提取物5g/L、NaCl 10g/L、琼脂15g/L),即置于30℃培养箱培养过夜。取单菌落接种于GMM培养液(6.7g/L YNB、0.2%葡萄糖)中,30℃、200rpm摇床过夜培养。4℃、3000rpm离心5min,预冷的无菌PBS洗涤2次,血细胞计数法计数,制备成浓度为3×10 6CFU/mL的菌悬液。取5mL菌悬液备用。制备取5mL PBS在其中加入25μL咖啡豆醇稀释液(浓度为6mg/mL,溶质为DMSO)至咖啡豆醇的终浓度为30μg/mL,取5mL PBS,在其中加入25μL DMSO。 (b) Preparation of Candida albicans suspension: activate Candida albicans standard strain SC5314 in LB solid medium (tryptone 10g/L, yeast extract 5g/L, NaCl 10g/L, agar 15g/L), namely Place in a 30°C incubator overnight. Take a single colony and inoculate it in GMM culture medium (6.7g/L YNB, 0.2% glucose), and cultivate overnight at 30°C on a shaker at 200rpm. Centrifuge at 4°C and 3000rpm for 5min, wash twice with pre-cooled sterile PBS, count by blood cell counting method, and prepare a bacterial suspension with a concentration of 3×10 6 CFU/mL. Take 5mL of bacterial suspension for later use. Preparation Take 5 mL of PBS and add 25 μL of kahweol diluent (concentration: 6 mg/mL, solute is DMSO) to the final concentration of kahweol to 30 μg/mL, take 5 mL of PBS, add 25 μL of DMSO to it.
(c)小鼠口腔侵染实验:小鼠感染前一天称重并每只注射0.1mL/10g的氢化可的松(22.5mg/mL,接种前,先用10%的水合氯醛麻醉小鼠,被麻醉的小鼠平放在37℃恒温环境中,用无菌棉球浸透菌悬液3min后放在小鼠舌头下90min; 同时设置空白对照组,空白对照组使用PBS溶液浸透无菌球棉后放在小鼠舌头下90min。然后第1、3、5天给每只小鼠灌100μL/10g的咖啡豆醇稀释液(浓度为30μg/mL,溶质为DMSO);同时设置阳性对照组,阳性对照组使用含有DMSO的PBS进行灌胃。第6天处死小鼠,把小鼠舌头进行解剖并进一步进行病理切片观察。(c) Mice oral infection experiment: the mice were weighed one day before infection and each injected with 0.1mL/10g of hydrocortisone (22.5mg/mL, before inoculation, the mice were anesthetized with 10% chloral hydrate , the anesthetized mice were placed flat in a constant temperature environment of 37°C, soaked in the bacterial suspension with sterile cotton balls for 3 minutes and then placed under the tongues of the mice for 90 minutes; at the same time, a blank control group was set up, and the blank control group soaked the sterile balls with PBS solution Put it under the tongue of the mouse for 90 minutes after cotton. Then, on the 1st, 3rd, and 5th day, each mouse was fed with 100 μL/10 g of cafeteria alcohol dilution (the concentration was 30 μg/mL, and the solute was DMSO); at the same time, a positive control group was set , the positive control group was gavaged with PBS containing DMSO. On the 6th day, the mice were sacrificed, and the tongues of the mice were dissected and further observed in pathological sections.
2、实验结果2. Experimental results
(1)咖啡豆醇和咖啡油醇抑制白色念珠菌菌株SC5314菌丝的形成(1) Caffeol and cafestol inhibit the mycelium formation of Candida albicans strain SC5314
图1是在显微镜下观察的白色念珠菌菌丝形成的照片图,其中按咖啡豆醇和咖啡油醇处理组相同体积的DMSO加入到菌液,在37℃培养作为对照组,以排除DMSO对白色念珠菌菌丝形成的影响。通过照片计算菌丝形成的抑制率:一个样品拍3张照(3个照片3个重复值),统计照片上的菌丝,以DMSO形成的菌丝为100%。结果如图2所示,咖啡豆醇和咖啡油醇分别对白色念珠菌SC5314有明显的菌丝抑制作用,经过终浓度为30μg/mL的咖啡豆醇或咖啡油醇处理后,白色念珠菌基本没有菌丝形成。Figure 1 is a photograph of the mycelium formation of Candida albicans observed under a microscope, in which the same volume of DMSO was added to the bacterial solution according to the kahwegol and kahweol treatment groups, and cultured at 37°C as a control group to exclude the effect of DMSO on white Effects on Candida hyphae formation. Calculate the inhibition rate of mycelium formation by photos: take 3 photos (3 photos with 3 repeated values) for one sample, count the mycelia on the photos, and the mycelium formed with DMSO is 100%. The results are shown in Figure 2, kahweol and cafestyl alcohol have obvious mycelial inhibitory effect on Candida albicans SC5314 respectively, and after treatment with kahweol or kahweol at a final concentration of 30 μg/mL, Candida albicans basically has no Mycelium formation.
(2)咖啡豆醇和咖啡油醇抑制白色念珠菌菌株SC5314的粘附性(2) Caffeol and cafestol inhibit the adhesion of Candida albicans strain SC5314
如图3所示,以DMSO为参照,经终浓度为30μg/mL的咖啡豆醇和咖啡油醇分别处理后的白色念珠菌在聚苯乙烯上的粘附性,降低了50%以上。表明咖啡豆醇和咖啡油醇分别显示出了对白色念珠菌SC5314的粘附性有一定抑制作用。As shown in FIG. 3 , taking DMSO as a reference, the adhesion of Candida albicans on polystyrene after being treated with kahweol and kahweol at a final concentration of 30 μg/mL was reduced by more than 50%. It shows that kahweol and cafestyl alcohol have a certain inhibitory effect on the adhesion of Candida albicans SC5314 respectively.
(3)咖啡豆醇和咖啡油醇对白色念珠菌菌株SC5314生物膜形成的影响:(3) Effects of cafestol and cafestyl alcohol on biofilm formation of Candida albicans strain SC5314:
如图4所示,以DMSO为参照,经咖啡豆醇或咖啡油醇(30μg/mL)处理后的白色念珠菌在聚苯乙烯上的生物膜形成,降低了90%以上。表明咖啡豆醇或咖啡油醇对白色念珠菌SC5314的生物膜形成有很好的抑制作用。As shown in FIG. 4 , taking DMSO as a reference, the biofilm formation of Candida albicans on polystyrene after being treated with cafestol or cafestyl alcohol (30 μg/mL) was reduced by more than 90%. It shows that cafestol or cafestyl alcohol has a good inhibitory effect on the biofilm formation of Candida albicans SC5314.
(4)高浓度的咖啡豆醇对白色念珠菌菌株SC5314的细胞生长具有轻微的抑制作用,低浓度的咖啡豆醇和咖啡油醇没有抑制作用;(4) High concentration of kahweol has a slight inhibitory effect on the cell growth of Candida albicans strain SC5314, and low concentration of kahweol and kahweol have no inhibitory effect;
结果显示,以DMSO为对照,咖啡豆醇的浓度为30μg/mL时对白色念珠菌菌株SC5314的生长有轻微的抑制作用(图5A),咖啡油醇没有抑制作用(图5B)。该结果表明咖啡豆醇或咖啡油醇对白色念珠菌菌株SC5314的治疗作用并不是主要通过杀死细菌细胞实现的,因此不易产生耐药性。The results showed that using DMSO as a control, cafestyl alcohol had a slight inhibitory effect on the growth of Candida albicans strain SC5314 at a concentration of 30 μg/mL ( FIG. 5A ), but cafestyl alcohol had no inhibitory effect ( FIG. 5B ). This result indicates that the therapeutic effect of cafestol or cafestyl alcohol on Candida albicans strain SC5314 is not mainly achieved by killing bacterial cells, and thus drug resistance is not easy to develop.
(5)咖啡豆醇或咖啡油醇对白色念珠菌菌株SC5314的细胞毒力有很好的抑制作用(5) Caffeol or cafestol has a good inhibitory effect on the cytotoxicity of Candida albicans strain SC5314
我们通过检测LDH的释放量来检测细胞毒力,在检测白色念珠菌的细胞毒力时,我们将在白色念珠菌SC5314中加入了DMSO组的LDH释放量作为100%, 并由此来规范其他加入咖啡豆醇或咖啡油醇组的LDH释放比例。结果如图6所示,数据显示的是4个生物学重复的平均结果,误差棒反映了标准差。We detect the cytotoxicity by detecting the release amount of LDH. When detecting the cytotoxicity of Candida albicans, we take the LDH release amount of the DMSO group added to Candida albicans SC5314 as 100%, and thereby standardize other LDH release ratio of kahweol or kahweol group. The results are shown in Figure 6, the data shown are the average of 4 biological replicates, and the error bars reflect the standard deviation.
细胞毒力实验结果显示,以DMSO为对照,在没有白色念珠菌的条件下,咖啡豆醇或咖啡油醇在30μg/mL的浓度时对细胞没有毒性,如图6A所示。The results of the cytotoxicity experiment showed that, using DMSO as a control, kahwegol or cafestyl alcohol had no toxicity to cells at a concentration of 30 μg/mL in the absence of Candida albicans, as shown in FIG. 6A .
而在加入白色念珠菌SC5314的条件下,以DMSO为对照,图6B显示咖啡豆醇或咖啡油醇对抑制SC5314对细胞的侵染有很好的保护作用;咖啡豆醇或咖啡油醇在30μg/mL的浓度时,白色念珠菌的毒力降低到30%以下。And under the condition of adding Candida albicans SC5314, using DMSO as a control, Figure 6B shows that cafestol or cafestyl alcohol has a good protective effect on inhibiting the invasion of cells by SC5314; /mL concentration, the virulence of Candida albicans was reduced to below 30%.
(6)咖啡豆醇对白色念珠菌菌株SC5314的小鼠口腔侵染有很好的抑制作用(6) Caffeol has a good inhibitory effect on the oral infection of Candida albicans strain SC5314 in mice
我们通过观察小鼠舌头上白色念珠菌形成情况,发现白色念珠菌对照组的小鼠舌头形成一层厚厚的白色念珠菌菌丝层,而在PBS空白对照组和咖啡豆醇处理组,小鼠舌头没有菌丝形成;病理切片(如图7)显示白色念珠菌对照组小鼠舌头细胞上层有白色念珠菌菌丝层,而PBS空白对照组和咖啡豆醇处理组则没有。By observing the formation of Candida albicans on the tongues of mice, we found that the tongues of the mice in the Candida albicans control group formed a thick mycelial layer of Candida albicans, while in the PBS blank control group and kahweol treatment group, the small There was no mycelium formation in the mouse tongue; pathological sections (as shown in Figure 7) showed that there was a mycelial layer of Candida albicans on the upper layer of the mouse tongue cells in the Candida albicans control group, but there was no mycelial layer in the PBS blank control group and the kahweol-treated group.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.

Claims (4)

  1. 咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用。Application of cafestol or derivatives thereof in preparation of anti-candida medicament or anti-candida daily necessities.
  2. 根据权利要求1所述的咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用,其特征在于:所述的抗白色念珠菌药物是具有抑制白色念珠菌的粘附性、菌丝形成、生物膜形成、致病性的药物。The application of cafestol or its derivatives according to claim 1 in the preparation of anti-Candida albicans medicine or anti-Candida albicans daily necessities, is characterized in that: described anti-Candida albicans medicine has the mucoid that inhibits Candida albicans Adhesion, mycelia formation, biofilm formation, pathogenic drug.
  3. 根据权利要求1所述的咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用,其特征在于:所述的抗白色念珠菌药物为用于预防和/或治疗白色念珠菌感染的药物,以及用于预防和/或治疗白色念珠菌引起的感染性疾病药物中的一种或两种。The application of cafestol or its derivatives according to claim 1 in the preparation of anti-Candida albicans medicaments or anti-Candida albicans daily necessities, characterized in that: the anti-Candida albicans medicaments are for prevention and/or treatment The medicine for Candida albicans infection, and one or both of the medicines for preventing and/or treating infectious diseases caused by Candida albicans.
  4. 根据权利要求1所述的咖啡醇或其衍生物在制备抗白色念珠菌药物或抗白色念珠菌日用品中的应用,其特征在于:所述的日用品为漱口水或阴道洗液。The use of cafestol or its derivatives according to claim 1 in the preparation of anti-Candida albicans medicine or anti-Candida albicans daily necessities, characterized in that: said daily necessities are mouthwash or vaginal lotion.
PCT/CN2022/080168 2021-08-20 2022-03-10 Use of caffeol or derivative thereof in preparation of anti-candida-albicans drug or anti-candida-albicans daily articles WO2023019924A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110960274.5 2021-08-20
CN202110960274.5A CN113648303B (en) 2021-08-20 2021-08-20 Application of cafestol or derivative thereof in preparation of anti-candida albicans medicine or anti-candida albicans daily product

Publications (1)

Publication Number Publication Date
WO2023019924A1 true WO2023019924A1 (en) 2023-02-23

Family

ID=78480548

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/080168 WO2023019924A1 (en) 2021-08-20 2022-03-10 Use of caffeol or derivative thereof in preparation of anti-candida-albicans drug or anti-candida-albicans daily articles

Country Status (2)

Country Link
CN (1) CN113648303B (en)
WO (1) WO2023019924A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113648303B (en) * 2021-08-20 2022-12-20 中山大学 Application of cafestol or derivative thereof in preparation of anti-candida albicans medicine or anti-candida albicans daily product

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978235B (en) * 1996-09-13 1998-03-03 E L Management Corp Topical composition and method for enhancing lipid barrier synthesis.
KR20050107876A (en) * 2004-05-10 2005-11-16 학교법인조선대학교 Pharmaceutical composition for anti-inflammation formation comprising cafestol or kahweol as an effective component
CN106573063A (en) * 2014-05-30 2017-04-19 奥尔胡斯大学 Cafestol for treating diabetes
CN113648303A (en) * 2021-08-20 2021-11-16 中山大学 Application of cafestol or derivative thereof in preparation of anti-candida albicans medicine or anti-candida albicans daily product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009107970A (en) * 2007-10-30 2009-05-21 Kirin Holdings Co Ltd AGENT FOR ENHANCING EXPRESSION OF IRON METABOLISM-RELATED GENE OF MACROPHAGE CONTAINING COMPOUND HAVING Nrf2 ACTIVATION ACTION AS ACTIVE INGREDIENT
AU2011210640A1 (en) * 2010-01-28 2012-06-07 The Johns Hopkins University Compositions and methods for reversing corticosteroid resistance or treating respiratory infections
BRPI1106762A2 (en) * 2011-12-22 2013-11-05 Bioactive Biomateriais Ltda POLYMERIC COMPOSITION CONTAINING NATURAL BIOACTIVES APPLICABLE IN PHARMACEUTICAL AND COSMETIC FORMULATIONS
AU2013293264B2 (en) * 2012-07-23 2017-08-31 Innovative Biodefense, Inc. Topical sanitizing formulations and uses thereof
GB2518826A (en) * 2013-09-27 2015-04-08 Thanasis Athanasiou Composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978235B (en) * 1996-09-13 1998-03-03 E L Management Corp Topical composition and method for enhancing lipid barrier synthesis.
KR20050107876A (en) * 2004-05-10 2005-11-16 학교법인조선대학교 Pharmaceutical composition for anti-inflammation formation comprising cafestol or kahweol as an effective component
CN106573063A (en) * 2014-05-30 2017-04-19 奥尔胡斯大学 Cafestol for treating diabetes
CN113648303A (en) * 2021-08-20 2021-11-16 中山大学 Application of cafestol or derivative thereof in preparation of anti-candida albicans medicine or anti-candida albicans daily product

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WANG, WENZHONG: "Coffee and Human Health", FAMILY MEDICINE, 1 September 2020 (2020-09-01), XP093037435, [retrieved on 20230404] *

Also Published As

Publication number Publication date
CN113648303A (en) 2021-11-16
CN113648303B (en) 2022-12-20

Similar Documents

Publication Publication Date Title
Shikov et al. Antibacterial activity of Chamomilla recutita oil extract against Helicobacter pylori
WO2023019924A1 (en) Use of caffeol or derivative thereof in preparation of anti-candida-albicans drug or anti-candida-albicans daily articles
CN105102441A (en) Antifungal compound and uses thereof
CN113730384B (en) Application of 4-methoxy phenanthrene-2, 5-diol in preparation of candida albicans resistant medicines or candida albicans resistant daily necessities
CN108926559A (en) Wedelolactone is preparing the application in anti-candida albicans drug
CN111419829B (en) Application of honokiol in inhibiting streptococcus suis or biofilm thereof
CN109843289B (en) Diaryl sulfur group compound for resisting candida albicans, preparation and application thereof
CN109646447B (en) Application of rhizoma paridis saponin in resisting malassezia furfur and candida albicans products
CN103974713A (en) Antimicrobial peptides for treatment of infectious diseases
CN108785291A (en) Application of the hypocrellin in the product for preparing anti-candida albicans
CN108578400B (en) Application of lysionotin in preparation of anti-candida albicans drugs
Mirabadi et al. In vitro activities of garlic essential oil against Candida species
CN112999205A (en) Application of efavirol in preparation of anti-candida albicans medicine
CN108653277B (en) Application of kavain derivative in preparation of anti-candida albicans medicine
CN110613720B (en) Application of veratrine in preparation of medicine for preventing and treating candida albicans infection
CN110141569B (en) Pharmaceutical composition for resisting pasteurella multocida
CN108186617B (en) New application of geraniol and derivatives thereof in preparation of MRSA infectious disease drugs
CN112089823A (en) Aureomycin A and nystatin composition and compound ointment, gel and spray thereof
CN108743575A (en) Application of the butyl p-hydroxybenzoate in preparing anti-candida albicans drug
CN108836976B (en) Application of ginsenoside RG5 in preparation of anti-Candida albicans medicine
CN108853120B (en) Application of fritillaria cirrhosa in preparation of anti-candida albicans medicines
CN114601829B (en) Application of N2 compound in preparation of antifungal drugs
Nehmatullah et al. Antimicrobial potential of some plant extracts against Candida species Isolated from infants oral thrush
Johnson et al. Effect of ketoconazole on the initial stages of germ tube formation by strains of Candida albicans
CN116637104A (en) Application of eastern leather lactone in preparation of candida albicans inhibition products

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22857244

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22857244

Country of ref document: EP

Kind code of ref document: A1